GlassScriptPhysician profile
Yogesh A Shah
NPI 1265510465
$159,090.80
in general payments reported to CMS, 2019-2025
10 companies · $73K in 2025
The $73K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.81 · 2021: $1,858 · 2022: $136 · 2023: $8,334 · 2024: $76K · 2025: $73K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $67K · Travel and Lodging: $35K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $26K · Consulting Fee: $26K · Food and Beverage: $2,813 · Honoraria: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $67,007.50 |
| Travel and Lodging | $34,610.76 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $26,170.00 |
| Consulting Fee | $25,598.75 |
| Food and Beverage | $2,812.98 |
| Honoraria | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $83,859.41 | 2023-2025 | Kisunla |
| Eisai INC. | $71,923.89 | 2023-2025 | |
| Biogen, INC. | $1,871.59 | 2021-2022 | |
| Lundbeck LLC | $800.00 | 2024 | Rexulti |
| Novo Nordisk INC | $248.83 | 2024-2025 | |
| Siemens Medical Solutions USA, INC. | $122.41 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $117.40 | 2023 | Rexulti |
| Sunovion Pharmaceuticals INC. | $59.97 | 2019 | |
| Life Molecular Imaging LTD | $50.46 | 2025 | Neuraceq |
| Amgen INC. | $36.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yogesh Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.